Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Powell

Showing results (191-200 of 248) with videos related to

Pageof 25
Sort By:
Frontiers in Psychiatry|August 8, 2014
Role of Environmental Confounding in the Association between FKBP5 and First-Episode PsychosisOlesya Ajnakina, Susana Borges, Marta Di Forti, et al.
Human Genetics|May 22, 2003
Sequence variation in the CHAT locus shows no association with late-onset Alzheimer's diseaseDenise Harold, Timothy Peirce, Valentina Moskvina, et al.
Nature Neuroscience|August 18, 2014
Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's diseaseKatie Lunnon, Rebecca Smith, Eilis Hannon, et al.
Arthritis and Rheumatism|December 30, 2006
Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192Christopher P Denton, Peter A Merkel, Daniel E Furst, et al.
The Lancet. Psychiatry|September 12, 2015
Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control studyMarta Di Forti, Arianna Marconi, Elena Carra, et al.
Human Mutation|February 17, 2005
Genetic association of the APP binding protein 2 gene (APBB2) with late onset Alzheimer diseaseYonghong Li, Paul Hollingworth, Pamela Moore, et al.
The New England Journal of Medicine|November 16, 2012
TREM2 variants in Alzheimer's diseaseRita Guerreiro, Aleksandra Wojtas, Jose Bras, et al.
Science Advances|February 19, 2019
A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's diseaseNicholas J Ashton, Alejo J Nevado-Holgado, Imelda S Barber, et al.
Cancer Cell|June 16, 2012
Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphomaYibin Yang, Arthur L Shaffer, N C Tolga Emre, et al.
Neuroscience Letters|March 18, 2004
Candidate gene association studies of the alpha 4 (CHRNA4) and beta 2 (CHRNB2) neuronal nicotinic acetylcholine receptor subunit genes in Alzheimer's diseaseLynnette J Cook, Luk W Ho, Alison E Taylor, et al.
Pageof 25

Showing results (191-200 of 248) with videos related to

Sort By:
Pageof 25
Frontiers in Psychiatry|August 8, 2014
Role of Environmental Confounding in the Association between FKBP5 and First-Episode PsychosisOlesya Ajnakina, Susana Borges, Marta Di Forti, et al.
Human Genetics|May 22, 2003
Sequence variation in the CHAT locus shows no association with late-onset Alzheimer's diseaseDenise Harold, Timothy Peirce, Valentina Moskvina, et al.
Nature Neuroscience|August 18, 2014
Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's diseaseKatie Lunnon, Rebecca Smith, Eilis Hannon, et al.
Arthritis and Rheumatism|December 30, 2006
Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192Christopher P Denton, Peter A Merkel, Daniel E Furst, et al.
The Lancet. Psychiatry|September 12, 2015
Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control studyMarta Di Forti, Arianna Marconi, Elena Carra, et al.
Human Mutation|February 17, 2005
Genetic association of the APP binding protein 2 gene (APBB2) with late onset Alzheimer diseaseYonghong Li, Paul Hollingworth, Pamela Moore, et al.
The New England Journal of Medicine|November 16, 2012
TREM2 variants in Alzheimer's diseaseRita Guerreiro, Aleksandra Wojtas, Jose Bras, et al.
Science Advances|February 19, 2019
A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's diseaseNicholas J Ashton, Alejo J Nevado-Holgado, Imelda S Barber, et al.
Cancer Cell|June 16, 2012
Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphomaYibin Yang, Arthur L Shaffer, N C Tolga Emre, et al.
Neuroscience Letters|March 18, 2004
Candidate gene association studies of the alpha 4 (CHRNA4) and beta 2 (CHRNB2) neuronal nicotinic acetylcholine receptor subunit genes in Alzheimer's diseaseLynnette J Cook, Luk W Ho, Alison E Taylor, et al.
Pageof 25